Anzeige
Mehr »
Sonntag, 26.10.2025 - Börsentäglich über 12.000 News
Das nächste Lila Sciences? Telescope Innovations ist das 30-Millionen-Dollar-Tor zu KI-gesteuerter Chemie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
10.10.Novo shutters cell therapy unit, ending work on potential Type 1 diabetes 'cure'
10.10.AstraZeneca to visit White House to formalize MFN agreement with Trump, MSNBC reports
10.10.Gilead's Yeztugo, Eisai's Leqembi Iqlik, Vertex's Journavx among 2025's best inventions: Time
10.10.Swiss auto-injector specialist Ypsomed invests $248M to build manufacturing facility in NC
10.10.Senate endorses Biosecure Act successor, adopting softer tone and omitting WuXi companies
10.10.Fierce Pharma Asia-TROP2 showdown; InnoCare, Zenas' $2B autoimmune deal; Lupin's US investment
10.10.Pelthos rolls out Zelsuvmi with campaign aimed at moms who 'don't mess around'
09.10.Planned summit hosted by DTC specialist BlinkRx raises concerns over ties to Trump admin: WSJ
09.10.AstraZeneca kicks off construction of $4.5B API plant in Virginia
09.10.Regeneron's Libtayo gains 'practice-changing' skin cancer label expansion
09.10.Lilly sponsors 'Project Runway' challenge to boost eczema's representation in pop culture
09.10.Lupin rides the onshoring wave, pledging $250M to build new respiratory production plant in Fla.
08.10.Ferring to reduce global headcount by 500 as part of reorganization
08.10.Vanda signs on as NHL's 1st pharma patch sponsor in Islanders deal, inks DC arena partnership
08.10.Zenas makes big bet on MS drug, striking $2B licensing deal with InnoCare
08.10.UK floats plan to fend off Trump tariffs by raising NHS drug spending threshold: Politico
08.10.Vifor to cut 55 jobs as parent company CSL pushes ahead with downsizing, savings drive
08.10.Galderma's Nemluvio itch relief claims scratched after Sanofi complaint
07.10.After high-profile FDA exit, Peter Marks lands at Eli Lilly
07.10.Novartis survey shines a light on hidden realities of women's conversations about breast health
07.10.Jury orders J&J to pay $966M in baby powder lawsuit
07.10.AbbVie taps Tyler James Williams to go 'Beyond a Gut Feeling' in new IBD campaign
07.10.OXB kicks off US expansion, buying viral vector plant in N.C. from National Resilience for $4.5M
06.10.Biogen told to pay $124M in patent dispute with Genentech
06.10.Eli Lilly earmarks $1B-plus for contract manufacturing partnerships in India